Condensed heterocyclic pyrazole derivatives as kinase inhibitors
US7541378B2 · kind B2 · utility
2Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 2003 |
| Grant date | Jun 2, 2009 |
| Priority date | — |
| Expiry date | Jul 12, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Bicyclo-pyrazole compound of formula (I) and pharmaceutically acceptable salts thereof, as defined in the specification, processes for their preparation, combinatorial libraries comprising a plurality of them and pharmaceutical compositions thereof, are herewith disclosed: the compounds of the invention are useful, in therapy, as protein kinase inhibitors, for instance in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.